Medical cannabis use in Australia consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and 2018 indicated that most consumers continued to use illicit medical cannabis products. Regulatory data indicate an increase in the prescription of medicinal cannabis since 2019, and this survey examines consumer experiences of prescribed and illicit medical cannabis (MC) use in Australia. A cross-sectional anonymous online survey was administered September 2020 to January 2021. Recruitment via social media, professional and consumer forums, and medical practices. Participant eligibility ≥ 18 years used a cannabis product for self-identified medical reason(s) in the past year, and resident in Australia. Outcome measures included consumer characteristics, conditions treated, source and patterns of MC use, and perspectives on accessing MC. Of the 1600 participants (mean age 46.4 ± 14.3 years, 53% male), 62.4% (n 999) reported using only illicit and 37.6% (n 601) used prescribed MC in the past year. MC was used on a median of 28 (IQR 12, 28) of the past 28 days and cost $AUD 74 ± 72 weekly (median $40, IQR $7, $100). Prescribed participants were more likely to treat pain conditions than those using illicit MC (52% v 40%, OR 1.7, 1.3-2.1) and less likely to treat sleep conditions (6% v 11%, OR 0.5, 0.3-0.8), with mental health conditions also a common indication in both groups (26%, 31%). Prescribed MC was consumed predominately by oral routes (72%), whereas illicit MC was most commonly smoked (41%). Prescribed MC was mainly THC (26%), equal THCCBD (40%), mainly CBD (31%) and uncertain (3%), while 34% of those using illicit MC were uncertain of the cannabinoid profile. Cost and difficulties finding medical practitioners to prescribe remain significant barriers to accessing prescribed MC, and few (10.8%) described the existing model for accessing prescribed MC as straightforward or easy. There has been a notable shift from illicit to prescribed MC by many consumers compared to prior surveys. Consumers using prescribed MC reported a range of advantages compared to illicit MC, including safer routes of administration, and greater certainty regarding access and composition of products.